Articles liés à Controlled Release of Drugs from Liposomes Using Ultrasound:...

Controlled Release of Drugs from Liposomes Using Ultrasound: A view into the physical, nano-technological, and biochemical principles that govern ultrasound facilitated drug delivery - Couverture souple

Schroeder, Avi; Kost, Joseph; Barenholz, Yechezkel

 
9783639247282: Controlled Release of Drugs from Liposomes Using Ultrasound: A view into the physical, nano-technological, and biochemical principles that govern ultrasound facilitated drug delivery
Couverture souple
ISBN 10 : 3639247280 ISBN 13 : 9783639247282
Editeur : VDM Verlag Dr. Müller, 2010

Synopsis

Liposomes, vesicles with one or more lipid bilayers entrapping an inner aqueous core, are widely used as drug delivery systems. When liposomes are smaller than 100 nanometers (nano liposomes) they have a unique capability of selectively accumulating in tumors and inflamed tissues. This phenomenon, known as the enhanced permeability and retention (EPR) effect, is related to the relatively high ?leakiness' of blood vessels in these diseased tissues. In this book, we present a novel approach for triggering drug release from liposomes at the target site, by use of a remote trigger ? low frequency ultrasound. The book includes detailed descriptions of formulation, characterization, and in vivo performance of liposome-based drugs, with focus and insights into the biophysical phenomena governing ultrasound-induced liposomal drug release. Special attention is given to the principles needed to formulate ultrasound-responsive liposomes. The book is intended for people entering the field of liposome-based drug delivery as well as experienced scientists seeking fundamental understanding of the mechanism by which ultrasound interacts with lipid bilayers.

Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.

Présentation de l'éditeur

Liposomes, vesicles with one or more lipid bilayers entrapping an inner aqueous core, are widely used as drug delivery systems. When liposomes are smaller than 100 nanometers (nano liposomes) they have a unique capability of selectively accumulating in tumors and inflamed tissues. This phenomenon, known as the enhanced permeability and retention (EPR) effect, is related to the relatively high ?leakiness' of blood vessels in these diseased tissues. In this book, we present a novel approach for triggering drug release from liposomes at the target site, by use of a remote trigger ? low frequency ultrasound. The book includes detailed descriptions of formulation, characterization, and in vivo performance of liposome-based drugs, with focus and insights into the biophysical phenomena governing ultrasound-induced liposomal drug release. Special attention is given to the principles needed to formulate ultrasound-responsive liposomes. The book is intended for people entering the field of liposome-based drug delivery as well as experienced scientists seeking fundamental understanding of the mechanism by which ultrasound interacts with lipid bilayers.

Biographie de l'auteur

This book presents an interdisciplinary study led by Dr. Yechezkel Barenholz, co-inventor of the FDA-approved liposomal drug ? Doxil; Dr. Joseph Kost, a pioneer in the field of ultrasound-based drug delivery systems; and Dr. Avi Schroeder, a PhD-student of the two, whose doctoral research serves as the basis for this book.

Les informations fournies dans la section « A propos du livre » peuvent faire référence à une autre édition de ce titre.

Éditeur
VDM Verlag Dr. Müller
Date d'édition
2010
Langue
anglais
ISBN 10 
3639247280
ISBN 13 
9783639247282
Reliure
Broché
Nombre de pages
112
Coordonnées du fabricant
non disponible
Personne responsable
non disponible